This recruits neutrophils into the tumor microenvironment and promotes the formation of neutrophil extracellular traps, which potently enhance tumor growth and impair cytotoxic immunity, suggesting SKAP1 as a promising therapeutic target in colon cancer. Here, SKAP1 is linked to colonic neoplasm.